Member access

4-Traders Homepage  >  Shares  >  Nyse  >  MEDNAX Inc    MD   US58502B1061

MEDNAX INC (MD)

6
Delayed Quote. Delayed Nyse - 08/22 04:04:32 pm
56.77 USD   -0.11%
2d ago MEDNAX : to Purchase MedData
5d ago MEDNAX : to Acquire Leading Revenue Cycle Management Company
08/14 MEDNAX : Acquires Anesthesiology Practices
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
MEDNAX Inc : Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Sales1 5881 8172 1542 4122 6552 945
Operating income (EBITDA)381420492557607666
Operating profit (EBIT)355390452512559620
Pre-Tax Profit (EBT)-388448---
Net income218241281317345381
EPS ( $)2,242,432,783,153,433,79
Dividend per Share ( $)------
Yield------
Announcement Date02/02/2012
11:00am
01/31/2013
11:00am
01/30/2014
11:00am
---
Finances - Leverage
MEDNAX Inc : Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Debt6,74116----
Finance--10,4125410317
Operating income (EBITDA)381420492557607666
Leverage
(Debt/EBITDA)
0,02x0,28x----
Capital Expenditure31,314,515,619,622,225,0
Book Value Per Share (BVPS)17,7 $20,3 $23,2 $25,3 $28,5 $33,2 $
Cash Flow per Share2,78 $3,28 $4,02 $3,91 $4,32 $4,98 $
Announcement Date02/02/2012
11:00am
01/31/2013
11:00am
01/30/2014
11:00am
---
Balance Sheet Analysis
MEDNAX Inc : Balance Sheet Analysis
Assessed data source :
© 2014 Thomson Reuters
Advertisement
Financial Ratios

Size 2014e 2015e
Capitalization 5 691 M$ -
Entreprise Value (EV) 5 566 M$ 5 281 M$
Valuation 2014e 2015e
PER (Price / EPS) 18,0x 16,5x
Capitalization / Revenue 2,36x 2,14x
EV / Revenue 2,31x 1,99x
EV / EBITDA 10,00x 8,70x
Yield (DPS / Price) - -
Profitability 2014e 2015e
Operating Margin (EBIT / Sales) 21,2% 21,1%
operating Leverage (Delta EBIT / Delta Sales) 1,10x 0,91x
Net Margin (Net Profit / Revenue) 13,1% 13,0%
ROA (Net Profit / Asset) 9,70% 9,63%
ROE (Net Profit / Equities) 12,5% 4,04%
Rate of Dividend - -
Balance Sheet Analysis 2014e 2015e
CAPEX / Sales   0,81% 0,84%
Cash Flow / Sales (Taux d'autofinancement) 16,2% 16,3%
Capital Intensity (Assets / Sales) 1,35x 1,35x
Financial Leverage (Net Debt / EBITDA) -0,22x -0,68x
EPS & Dividend
MEDNAX Inc : EPS Dividend
Dynamic quotes  
ON
| OFF